Recently, Rangsitratkul et al. armed VSVd51 with GM-CSF [52], treated human and mouse BC cells or spheroids with VSVd51-m/hGM-CSF, and observed the enhanced release of immunogenic factors and anger signals. Here, CSF2 is linked to breast cancer.